secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-06-30T23:59:59+00:00
Accession:  0001641172-25-017152
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel shareholders reelect directors, approve equity plan increase, endorse executive pay
--------------------------------------------------------------------------------

- Re-elected all five director nominees with over 99.97% support each.
- Approved amendment to 2018 Equity Incentive Plan increasing share reserve by 4,281,987 shares (99.94% votes for).
- Advisory vote on executive compensation passed with 99.95% votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225017152/0001641172-25-017152-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000164117225017152/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-017152

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer